Lithium Chile Inc. Price Target Is Maintained at C$1.57/Share by Fundamental Research
Lithium Chile Inc. Price Target Is Maintained at C$1.57/Share by Fundamental Research
Lithium Chile Inc. Restructures for Growth
MONUMENTAL ENERGY ENTERS INTO AN OPTION ACQUISITION AGREEMENT FOR THE TRANSFER OF THE SALAR DE TURI PROJECT
Lithium Chile Inc. Reports Major Lithium Resource Surge
Individual Investors in Lithium Chile Inc. (CVE:LITH) Are Its Biggest Bettors, and Their Bets Paid off as Stock Gained 18% Last Week
Portofino and Lithium Chile Partner on Winning Bid For Arizaro Lithium Project in Salta, Argentina
Portofino Resources (POR.V) and Lithium Chile (LITH.V) on Monday announced a 50:50 net equity Partnership Agreement after a successful tender for an 8,445 hectare concession within the lithium-bearing Arizaro Salar in Argentina (Arizaro Area IV).
Lithium Chile's Subsidary, Argentum Lithium, Awarded 8,445 Hectares on the Salar De Arizaro by REMSa
Lithium Chile Inc. Price Target Is Maintained at C$1.55/Share by Fundamental Research
Lithium Chile Inc. Price Target Is Maintained at C$1.55/Share by Fundamental Research
Lithium Chile Inc. (OTCMKTS:LTMCF) Short Interest Down 67.8% in January
Lithium Chile Inc. (OTCMKTS:LTMCF – Get Rating) was the recipient of a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling 6,800
Short Interest in Lithium Chile Inc. (OTCMKTS:LTMCF) Grows By 93.0%
Lithium Chile Inc. (OTCMKTS:LTMCF – Get Rating) saw a large growth in short interest in December. As of December 30th, there was short interest totalling 11,000 shares, a growth of 93.0% from the De
Lithium Chile Inc. (OTCMKTS:LTMCF) Sees Large Increase in Short Interest
Lithium Chile Inc. (OTCMKTS:LTMCF – Get Rating) was the target of a significant increase in short interest in November. As of November 15th, there was short interest totalling 75,000 shares, an incr
Lithium Chile Inc. (OTCMKTS:LTMCF) Sees Significant Decrease in Short Interest
Lithium Chile Inc. (OTCMKTS:LTMCF – Get Rating) saw a significant decline in short interest in the month of October. As of October 31st, there was short interest totalling 7,500 shares, a decline of
Short Interest in Lithium Chile Inc. (OTCMKTS:LTMCF) Expands By 6,200.0%
Lithium Chile Inc. (OTCMKTS:LTMCF – Get Rating) saw a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 6,300 shares, an incr
LITHIUM CHILE PROVIDES OPERATIONAL UPDATE ON THE PHASE TWO DEVELOPMENT PROGRAM ON ITS SALAR De ARIZARO PROJECT LOCATED IN SALTA PROVINCE, ARGENTINA WHERE FIELD TESTS FROM THE FIRST STEP OUT WELL RETURNED LITHIUM GRADES IN EXCESS OF 340 MG/L
TSX Venture Exchange: LITH For Immediate ReleaseOTC-BB: LTMCFCALGARY, ALBERTA, September 14, 2022, Sept. 14, 2022 (GLOBE NEWSWI
Short Interest in Lithium Chile Inc. (OTCMKTS:LTMCF) Drops By 95.0%
Lithium Chile Inc. (OTCMKTS:LTMCF – Get Rating) saw a significant drop in short interest in August. As of August 31st, there was short interest totalling 100 shares, a drop of 95.0% from the August
Short Interest in Lithium Chile Inc. (OTCMKTS:LTMCF) Rises By 1,922.2%
Lithium Chile Inc. (OTCMKTS:LTMCF – Get Rating) was the target of a significant growth in short interest during the month of July. As of July 15th, there was short interest totalling 18,200 shares,
MONUMENTAL MINERALS CORP. ENTERS INTO DEFINITIVE OPTION AGREEMENT WITH LITHIUM CHILE INC. TO ACQUIRE UP TO 75% OF THE SALAR DE LAGUNA BLANCA, CHILE CESIUM SALT-LITHIUM BRINE PROJECT
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, March 31, 2022 /CNW/ - Monumental Minerals Corp. ("Monumental" or the "Company") (TSXV
Lithium Chile Inc. Price Target Raised to C$1.53/Share From C$0.70 by Fundamental Research
Lithium Chile Inc. Price Target Raised to C$1.53/Share From C$0.70 by Fundamental Research
Lithium Chile Inc. Is Maintained at Buy by Fundamental Research
Lithium Chile Inc. Is Maintained at Buy by Fundamental Research
Modena data show that the immune effect of COVID-19 vaccine may be weakened to support promotion and strengthening needles.
Us drugmaker Modena (Moderna Inc) released more data on COVID-19 's "breakthrough infection" cases on Wednesday, supporting the need to promote the widespread use of COVID-19 vaccine to strengthen needles. A new analysis of the phase III study published by Modena shows that the incidence of "breakthrough infection" is lower in a group of participants who were recently vaccinated with COVID-19, indicating that the immune effect of people vaccinated early with COVID-19 has begun to weaken. Among the 11431 people who received COVID-19 vaccine between December last year and March this year, 88 cases of "breakthrough infection" were confirmed, the company said in a press release.
No Data